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Abstract The initiation of sporulation in Bacillus subtilis is 
under control of the transcriptional factor Spo0A. Most Spo0A 
mutants fail to initiate the sporulation process and aH the 
sporulation initiated processes uch as the synthesis of subtilisin. 
However, the product of spoOd9V, one of the several spo0A 
mutants characterized, distinguishes itself in the fact that, while 
it appears to effectively repress abrB, it fails to activate the 
spollA operon. The aim of this study was to examine the effect of 
the spoOA9V mutation on aprE expression and we found that in 
different genetic backgrounds, the spoOA9V mutation has a 
negative ffect on aprE: :lacZ expression. 
Key words: Sporulation; abr B expression; ~-Galactosidase 
fusion; Phosphorelay; Transition state regulator 
1. Introduction 
The initiation of sporulation in Bacillus subtilis is under 
control of the Spo0A transcriptional factor. Spo0A belongs 
to a large family of phosphorylation-activated signal trans- 
duction proteins that regulate adaptative responses in bacteria 
[1]. It is phosphorylated by a complex phosphorelay that in- 
cludes several components needed to integrate multiple signals 
[2]. The spoOA gene product regulates negatively the abrB 
gene [3,4], a repressor of several genes which transcription is
initiated during the transition between exponential growth 
and stationary phase [5]. As a positive effector, Spo0A is in- 
dispensable for activating the expression of at least three im- 
portant stage II genes or operons [6]. Different mutants of 
spoOA gene have been isolated. Among them, the spoOA9V 
gene product (Spo0A9V) represses abrB but fails to activate 
the spollA operon. Also, as deduced from qualitative assays 
on milk plates, when a strain carries the spoOA9V allele, the 
production of extracellular proteases appears normal [7]. 
These data support the suggestion that in a strain carrying 
the spoOA9V mutation, it is possible to dissociate the positive 
and negative regulatory properties of Spo0A [7]. 
The aprE gene of Bacillus subtilis codes for the extracellular 
protease subtilisin and its expression is controlled by Spo0A, 
AbrB and several other regulators [8]. In the present study we 
examined the effect of the spoOA9V mutation on aprE expres- 
sion. We have found that in different genetic backgrounds, the 
spoOA9V mutation has a negative ffect on aprE expression. 
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2. Materials and methods 
2.1. Bacterial strains and plasmids 
The genotypes of bacterial strains used in this work are listed in 
Table 1. All strains are derivatives of BG125 [9]. Strain JH13541 was 
kindly provided by J. Hoch. The rest of the strains were construct- 
ed for this study using the method described by Anagnostopoulos 
and Spizizen in [10]. To measure aprE gene expression we used an 
aprE: :lacZ fusion integrated in the amy locus, as previously described 
[9]. 
2.2. ~-Galactosidase assays 
B. subtilis cells carrying pSG35.1 and pSub-204 (Fig. 1) were grown 
at 37°C in Schaeffer's porulation media [11]. At regular time inter- 
vals, samples of 1 ml were taken and assayed for B-galactosidase 
specific activity as described in [9]. 
2.3. Plasmid construction 
Plasmid pSub-204 was constructed using standard recombinant 
DNA techniques. A DNA fragment that contains part of the aprE 
regulatory region was generated using the polymerase chain reaction 
(PCR) and the synthetic primers Subl and Sub2. The sequence of 
the primers is the following: 5'GGAATTCGGACTCAGGAGC- 
ATTTAACCY (Subl); 5'CGGGATCCCGTTAACGCAAACAA- 
CAAGCY (Sub2). These primers hybridize with the -204 to -185 
region of the aprE regulatory region and from the +83 to +100 of the 
aprE structural gene respectively [12]. The recognition sequence for 
the EcoRI or BamHI restriction enzymes were introduced in the pri- 
mers to facilitate the cloning of the DNA fragment into pSG35.1 (see 
Fig. 1). 
3. Results and discussion 
Since the mutation spoOA9V generates a SpoOA protein 
that can still repress abrB efficiently, but cannot activate the 
transcription of the spollA operon [7], we were interested in 
studying the effect of such mutation on aprE expression in 
different genetic backgrounds. For such a purpose we con- 
structed the B. subtilis strains described in Table 1. It is im- 
portant to mention that hpr2 [13] and degU32 [14~16] muta- 
tions cause aprE overexpression and that their effects are 
synergistic [9 17]. We measured aprE expression using an 
aprE::lacZ fusion in all these strains. In all the analyzed 
strains, [3-galactosidase p aked between 2 and 3 h after ending 
exponential growth (data not shown). To facilitate compari- 
sons between strains, the ~-galactosidase pecific activities 
reached at T2 were compared. As can be seen in Table 2, 
the spoOA9V mutation had a negative effect, even in the 
strains carrying the degU32 or hpr2 mutations that cause 
aprE over-expression. The level of 13-galactosidase activity 
was approximately 5-fold lower in the spoOA9V background 
in all the analyzed strains. We believe that such difference is 
small for a qualitative assay, like the measurement of halos on 
skim milk plates, and could explain the discrepancy between 
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our data and the ones reported in [7]. This suggestion is also 
supported by the fact that milk plates reflect more accurately 
the levels of the neutral protease NprE. 
These data suggest that a fully functional Spo0A is needed 
for an adequate aprE expression. Since abrB is regulated nor- 
mally in a spoOA9V background [7], Spo0A should have an- 
other role on aprE expression (see below). The fact that the 
negative ffect of spoOA9V was observed even in a hpr2 mu- 
tant, suggests that this effect is not due to a secondary effect 
on hpr. It is also clear that the degU32 mutation does not 
overcome the repressive ffect of spoOA9V. 
A possible xplanation for these results could be that in the 
spoOA9V mutant, SinR activity is not adequately regulated. 
SinR is a regulator that prevents premature xpression of 
stage II sporulation genes [18-20]. Its overproduction has a 
negative ffect on aprE expression [21]. Furthermore, purified 
SinR binds to a specific region on the aprE regulatory region 
[22]. It is known that SinR is regulated by the action of SinI 
by protein-protein i teraction, and that in a spoOA mutant, 
sinI is repressed [23]. 
To test this hypothesis, we analyzed again the effect of 
spoOA9V mutation in wt, hpr2 and degU32 strains. However, 
in this set of experiments, we used an aprE regulatory region 
devoided of the SinR binding site as shown in Fig. 1; it is 
known that such regulatory region is insensitive to SinR re- 
pression [12,18]. Essentially, this construction is the same as 
the one reported previously [12] in plasmid pSG35.8 and in- 
tegrated into the amy locus. However, because we have found 
that some of the original construct carry an uncharacterized 
deletion on the aprE regulatory region, we built a new plasmid 
called pSub-204 carrying the upstream region of the aprE 
promoter up to the --204 position (PaprE--2o4) (Fig. 1). The 
correct integration and size of this fusion was corroborated by 
PCR (data not shown). 
After measuring -galactosidase levels in these strains (Ta- 
ble 3) it was found that in a wt background, after deleting the 
SinR binding site of the aprE regulatory region, the negative 
effect of the spoOA9V mutation disappeared. The same results 
was obtained in an hpr2 background. Here is important o 
mention that as previously reported, and by unknown rea- 
sons, the effect of the hpr2 mutation on this shorter version 
of the aprE regulatory region, is lost [12]. Furthermore, 
PaprE-2o4 lost partially its capacity to respond to the 
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Fig. 1. Construction of plasmid pSub-204. Using PCR and synthetic 
oligonucleotides Subl and Sub2 (see section 2), a DNA fragment 
comprising part of the aprE regulatory region was obtained. It con- 
tains the putative DegU recognition site, two of the Hpr binding 
sites (Hpr3 and Hpr4) and the AbrB binding site previously located 
(17,3). These sites as well as other relevant features of this DNA 
fragment are also indicated. 
repression factor due to the spoOA9V mutation was similar 
(see Tables 2 and 3). 
These data indicate that part of the negative ffect of the 
spoOA9 V mutation is due to the binding of SinR to the aprE 
regulatory region. However in a degU32 background, a fully 
functional Spo0A is required for maximal expression. 
Recently it has been reported that a mutation in spoOA gene 
codon 97, suppressed the sporulation defect caused by the 
Strain Genotype or description Source and/or Ref. 
BB17 BB80 degU32 E. Ferrari 
BB80 Anpr hisA glyB E. Ferrari 
BB82 Anpr hisA hpr2 E. Ferrari 
BB809 BB80 amy(aprE: :lacZ) cat This work 
BB810 BB82 amy(aprE:.'lacZ) cat This work 
BB811 BB809 degU32 This work 
BB812 BB80 amy(paprE2o4: :lacZ) cat This work 
BB813 BB82 amy (papr~204 : :lacZ) cat This work 
BB814 BB812 degU32 This work 
JH13541 spoOA9Vphe J. Hoch 
BB815 BB809 spoOA9V This work 
BB816 BB810 spoOA9V This work 
BB817 BB811 spoOA 9V This work 
BB818 BB812 spoOA9V This work 
BB819 BB813 spoOA9V This work 
BB820 BB814 spoOA9V This work 
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Table 2 
[3-Galactosidase pecific activity of the PaprE: lacZ fusion at T2 
wt spoOA9 V Ratio 
wtlspoOA 9 V 
wt 2,262 394 5.7 
hpr2 10,500 2446 4.3 
degU32 55,600 8835 6.3 
31 
Table 3 
l]-Galactosidase specific activity of the PaprE-2o4." :lacZ fusion at T2 
wt spoOA9 V Ratio 
wtlspoOA9 V 
wt 1194 1024 1.1 
hpr2 1273 972 1.3 
degU32 23813 4353 5.5 
spoOA9V mutation. This suppression was evident only in the 
presence of a mutation in the spoOH locus [24]. This result 
support the hypothesis that Spo0A interacts directly with the 
transcription machinery [7]. 
The fact that spoOA9V revertants required a mutation on 
spoOH is important because apparently 5n, transcribes a di- 
verse group of genes that play important roles in the bacter- 
ium responses to nutrient depletion, and it is required to am- 
plify the response initiated by Spo0A-P [25]. In this sense, it is 
known that a deletion of spoOH lowers aprE: :lacZ expression 
approximately five-fold [26], the same value observed in the 
spoOA9 V mutants. 
Based on these, it is possible to speculate that in a spoOA9V 
mutant, some genes of the 5nregulon that require a direct 
interaction between Spo0H and Spo0A-P, are not properly 
activated or repressed. 
Finally, the data presented in this paper support he notion 
that in B. subtilis, the aprE gene can be expressed at different 
levels; one is obtained in wt strains under normal laboratory 
conditions, and is controlled by Spo0A mainly through the 
action of SinR. Another level is only obtained through the 
action of degU32 mutation, and requires a fully functional 
Spo0A. This level of expression depends on an unidentified 
signal. 
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